Condition
Clotting Disorder
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 4 (2)
Trial Status
Completed3
Terminated1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06227819Completed
BVA-200 vs BVA-100 Validation Study
NCT05237492Phase 4Completed
The Influence of Tramadol on Platelet Function
NCT05387577Early Phase 1Terminated
Coagulation and Fibrinolysis of Estradiol in Transwomen
NCT04824118Completed
Clotting Parameters After Medical Abortion
NCT03962400Phase 4WithdrawnPrimary
Reinforcement Learning for Warfarin Dosing
Showing all 5 trials